- Home
- INMB vs RMI Comparison
INMB vs RMI Comparison
Compare INMB & RMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- RMI
- Stock Information
- Founded
- INMB 2015
- RMI 2018
- Country
- INMB United States
- RMI United States
- Employees
- INMB N/A
- RMI N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- RMI Finance/Investors Services
- Sector
- INMB Health Care
- RMI Finance
- Exchange
- INMB Nasdaq
- RMI Nasdaq
- Market Cap
- INMB 103.1M
- RMI 95.7M
- IPO Year
- INMB 2019
- RMI N/A
- Fundamental
- Price
- INMB $6.53
- RMI $15.59
- Analyst Decision
- INMB Strong Buy
- RMI
- Analyst Count
- INMB 2
- RMI 0
- Target Price
- INMB $21.00
- RMI N/A
- AVG Volume (30 Days)
- INMB 369.6K
- RMI 17.4K
- Earning Date
- INMB 10-31-2024
- RMI 01-01-0001
- Dividend Yield
- INMB N/A
- RMI 7.28%
- EPS Growth
- INMB N/A
- RMI N/A
- EPS
- INMB N/A
- RMI N/A
- Revenue
- INMB $42,000.00
- RMI N/A
- Revenue This Year
- INMB N/A
- RMI N/A
- Revenue Next Year
- INMB N/A
- RMI N/A
- P/E Ratio
- INMB N/A
- RMI N/A
- Revenue Growth
- INMB N/A
- RMI N/A
- 52 Week Low
- INMB $4.32
- RMI $13.05
- 52 Week High
- INMB $14.74
- RMI $17.37
- Technical
- Relative Strength Index (RSI)
- INMB 64.22
- RMI 59.71
- Support Level
- INMB $6.04
- RMI $15.34
- Resistance Level
- INMB $6.83
- RMI $15.54
- Average True Range (ATR)
- INMB 0.56
- RMI 0.17
- MACD
- INMB 0.17
- RMI 0.07
- Stochastic Oscillator
- INMB 86.76
- RMI 87.21
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.
About RMI RiverNorth Opportunistic Municipal Income Fund Inc.
RiverNorth Opportunistic Municipal Income Fund, Inc. is a diversified, closed-end management investment company. Its investment objective is to seek current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.